Priorities for the treatment of latent tuberculosis

N Engl J Med. 2004 Aug 19;351(8):832-4; author reply 832-4. doi: 10.1056/NEJM200408193510823.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Humans
  • Risk Factors
  • Tuberculosis / epidemiology
  • Tuberculosis / prevention & control*

Substances

  • Antitubercular Agents